A Current Overview of Next-Generation Probiotics and Their Prospects in Health and Disease Management

Traditional probiotics have been extensively studied, and their effectiveness in gut modulation is well established. However, emerging research has shifted focus to previously understudied probiotic strains, now known as next-generation probiotics (NGPs), with the aim of harnessing their unique potential to elicit targeted therapeutic effects in disease management. This study aims to provide a comprehensive review on the recent evidence on NGPs by exploring their potential roles and applications in human health and agricultural settings. The literature search was conducted systematically across four databases with the keywords “next generation probiotics” and “gut health” or treatment” or “therapy”. The findings of this review identified promising NGPs, including Akkermansia muciniphila, Bacillus sp., Bacteroides sp., Enterococcus sp., Faecalibacterium sp., Parabacteroides sp., and Streptomyces sp. These NGPs can elicit targeted effects in specific disease states while simultaneously restore gut dysbiosis by promoting beneficial bacteria, elevated short-chain fatty acid levels, and stimulate immunomodulatory effects to reduce inflammation. These modes of action are closely linked to one another, acting as a positive feedback loop to reduce inflammation in the host. Besides, other niche NGPs that are lesser-studied also show therapeutic effects in disease management, highlighting the importance of further research into these species to uncover potential mechanistic pathways for treating various illnesses. In summary, NGPs can offer targeted therapeutic effects in addition to probiotic effects in the gut, providing a multi-faceted approach in treating various health conditions. The development of therapeutics with these NGPs could offer alternatives to current treatment strategies to improve disease outcomes and prognosis. Nevertheless, future research is essential to better elucidate the exact mechanisms, safety profiles, and therapeutic applications of these NGPs. Graphical abstract: The potential therapeutic applications of NGPs.

Authors

Publication Details

Journal
Progress In Microbes & Molecular Biology
Published
2024-12-29
DOI
https://doi.org/10.36877/pmmb.a0000457
Citations
4
Primary Topic
Probiotics and Fermented Foods
Type
article
Field-Weighted Citation Impact
1.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Current Overview of Next-Generation Probiotics and Their Prospects in Health and Disease Management

Kok‐Gan Chan, Jodi Woan‐Fei Law, Loh Teng‐Hern Tan, Ke-Yan Loo et al.
4 citations
Progress In Microbes & Molecular Biology
Probiotics and Fermented Foods
1.39
article

A Current Overview of Next-Generation Probiotics and Their Prospects in Health and Disease Management

Kok‐Gan Chan, Jodi Woan‐Fei Law, Loh Teng‐Hern Tan, Ke-Yan Loo, Vengadesh Letchumanan, Learn−Han Lee, Joanne Yuen Heng Thong
article en
4 citations

Abstract

Traditional probiotics have been extensively studied, and their effectiveness in gut modulation is well established. However, emerging research has shifted focus to previously understudied probiotic strains, now known as next-generation probiotics (NGPs), with the aim of harnessing their unique potential to elicit targeted therapeutic effects in disease management. This study aims to provide a comprehensive review on the recent evidence on NGPs by exploring their potential roles and applications in human health and agricultural settings. The literature search was conducted systematically across four databases with the keywords “next generation probiotics” and “gut health” or treatment” or “therapy”. The findings of this review identified promising NGPs, including Akkermansia muciniphila, Bacillus sp., Bacteroides sp., Enterococcus sp., Faecalibacterium sp., Parabacteroides sp., and Streptomyces sp. These NGPs can elicit targeted effects in specific disease states while simultaneously restore gut dysbiosis by promoting beneficial bacteria, elevated short-chain fatty acid levels, and stimulate immunomodulatory effects to reduce inflammation. These modes of action are closely linked to one another, acting as a positive feedback loop to reduce inflammation in the host. Besides, other niche NGPs that are lesser-studied also show therapeutic effects in disease management, highlighting the importance of further research into these species to uncover potential mechanistic pathways for treating various illnesses. In summary, NGPs can offer targeted therapeutic effects in addition to probiotic effects in the gut, providing a multi-faceted approach in treating various health conditions. The development of therapeutics with these NGPs could offer alternatives to current treatment strategies to improve disease outcomes and prognosis. Nevertheless, future research is essential to better elucidate the exact mechanisms, safety profiles, and therapeutic applications of these NGPs. Graphical abstract: The potential therapeutic applications of NGPs.

Progress In Microbes & Molecular BiologyVol. 7(1)
University of Nottingham Ningbo China
Zero hunger
Openalex Percentile: Top 18%
Probiotics and Fermented Foods
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.